retatrutide phase 2 diabetes weight loss 2024 💉 may be redefining obesity treatment. New data from TRIUMPH-1 Trial showed: 🔥 ~28% average over 80 weeks 🔥 >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic Lilly's triple agonist achieves 16.8%

GLP-1 medications such as Tirzepatide and Semaglutide work by reducing appetite, controlling cravings, improving fullness, and helping the body use energy more efficiently leading to steady, sustainable fat loss without restrictive diets or surgery

This could make it easier for everyone to find better drink options

In T cell adoptive transfer-induced colitis, the GLP-1 expression in colonic tissue was significantly lower in mice with colitis when compared with control mice (Schmidt et al

After 3 h of incubation, the cells were washed five times with cold HBSS, and immediately stored at 20 C until analysis

Dubin JM et al

The dosage chart is your roadmap, but your healthcare provider is your navigator